NFKB1 and atherosclerosis: Due to the inhibition of RhoA/ROCK/NF-κB signaling in human endothelial cells ECV-304, SFN attenuated TNF-α-induced ICAM-1 expression, as well as IKK phosphorylation, suggesting a beneficial role in the atherosclerosis-related inflammation [144–146].